| Year |
Citation |
Score |
| 2021 |
Carnahan LR, Abdelrahim R, Ferrans CE, Rizzo GR, Molina Y, Handler A. Rural Cancer Disparities: Understanding Implications for Breast and Cervical Cancer Diagnoses. Clinical Journal of Oncology Nursing. 25: 10-16. PMID 34533527 DOI: 10.1188/21.CJON.S1.10-16 |
0.307 |
|
| 2020 |
Jang MK, Kim S, Park CG, Collins EG, Quinn LT, Ferrans CE. Quality of Life and Prolonged Symptoms in Korean Breast Cancer Survivors. Cancer Nursing. PMID 33003122 DOI: 10.1097/NCC.0000000000000894 |
0.351 |
|
| 2020 |
Mizuno M, Munezawa N, Yamashita M, Sasahara T, Mayers T, Park C, Ferrans CE. Reliability and validity of the Japanese version of the Quality of Life Index for patients with cancer. Research in Nursing & Health. PMID 31985085 DOI: 10.1002/nur.22011 |
0.309 |
|
| 2020 |
Bergeron NQ, Strahan M, Strayhorn S, Khanna A, Villines D, Watson K, Ferrans C, Molina Y. Abstract A023: Do African American informal caregivers’ breast cancer fear and cultural misconceptions predict the spread of breast cancer misinformation among their social networks? Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-A023 |
0.34 |
|
| 2019 |
Jang MK, Hershberger PE, Kim S, Collins E, Quinn LT, Park CG, Ferrans CE. Factors Influencing Surveillance Mammography Adherence Among Breast Cancer Survivors. Oncology Nursing Forum. 46: 701-714. PMID 31626613 DOI: 10.1188/19.Onf.701-714 |
0.303 |
|
| 2019 |
Strayhorn SM, Carnahan LR, Zimmermann K, Hastert TA, Watson KS, Ferrans CE, Molina Y. Comorbidities, treatment-related consequences, and health-related quality of life among rural cancer survivors. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 31342166 DOI: 10.1007/s00520-019-05005-7 |
0.334 |
|
| 2017 |
Tejeda S, Stolley MR, Vijayasiri G, Campbell RT, Ferrans CE, Warnecke RB, Rauscher GH. Negative Psychological Consequences of Breast Cancer among Recently Diagnosed Ethnically Diverse Women. Psycho-Oncology. PMID 28499328 DOI: 10.1002/Pon.4456 |
0.375 |
|
| 2017 |
Sighoko D, Murphy AM, Irizarry B, Rauscher G, Ferrans C, Ansell D. Changes in the racial disparity in breast cancer mortality in the ten US cities with the largest African American populations from 1999 to 2013: The reduction in breast cancer mortality disparity in Chicago. Cancer Causes & Control : Ccc. PMID 28275936 DOI: 10.1007/S10552-017-0878-Y |
0.357 |
|
| 2014 |
Silva A, Rauscher GH, Ferrans CE, Hoskins K, Rao R. Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry. Journal of Registry Management. 41: 24-30. PMID 24893185 |
0.331 |
|
| 2014 |
Gallardo RI, Rauscher G, Ferrans C. Abstract B03: Cultural beliefs among Latina women: The role of acculturation and impact on timeliness of breast cancer care Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-B03 |
0.399 |
|
| 2013 |
Silva A, Rauscher GH, Hoskins K, Rao R, Ferrans CE. Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines. Breast Cancer Research and Treatment. 142: 667-72. PMID 24265033 DOI: 10.1007/S10549-013-2759-8 |
0.304 |
|
| 2011 |
Grutsch JF, Ferrans C, Wood PA, Du-Quiton J, Quiton DF, Reynolds JL, Ansell CM, Oh EY, Daehler MA, Levin RD, Braun DP, Gupta D, Lis CG, Hrushesky WJ. The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. Bmc Cancer. 11: 193. PMID 21605390 DOI: 10.1186/1471-2407-11-193 |
0.357 |
|
| 2009 |
Hrushesky WJ, Grutsch J, Wood P, Yang X, Oh EY, Ansell C, Kidder S, Ferrans C, Quiton DF, Reynolds J, Du-Quiton J, Levin R, Lis C, Braun D. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integrative Cancer Therapies. 8: 387-97. PMID 19926611 DOI: 10.1177/1534735409352086 |
0.357 |
|
| 2009 |
Ansell D, Grabler P, Whitman S, Ferrans C, Burgess-Bishop J, Murray LR, Rao R, Marcus E. A community effort to reduce the black/white breast cancer mortality disparity in Chicago. Cancer Causes & Control : Ccc. 20: 1681-8. PMID 19688184 DOI: 10.1007/S10552-009-9419-7 |
0.393 |
|
| 2006 |
Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D, Aaronson N, Barofsky I, Bonomi A, Bullinger M, Cappelleri J, Fairclough D, et al. The clinical significance of quality of life assessments in oncology: A summary for clinicians Supportive Care in Cancer. 14: 988-998. PMID 16794811 DOI: 10.1007/S00520-006-0085-Y |
0.321 |
|
| 2003 |
Guyatt G, Ferrans C, Halyard M, Revicki DA, Symonds T, Varricchio C, Alonso J. What is the value added to the clinician of health-related quality-of-life information from clinical research and using QOL measures in clinical practice? Clinical Therapeutics. 25. DOI: 10.1016/S0149-2918(03)80245-X |
0.33 |
|
| 2002 |
Frost MH, Bonomi AE, Ferrans CE, Wong GY, Hays RD. Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clinic Proceedings. 77: 488-94. PMID 12004999 DOI: 10.1016/S0149-2918(02)85091-3 |
0.329 |
|
| Show low-probability matches. |